By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Rasna Therapeutics 

3443 Whittier Street

San Diego  California  92106-1614  U.S.A.
Phone: 858-226-4651 Fax: n/a


SEARCH JOBS

Rasna Therapeutics, Inc. is a development stage biotechnology company focused primarily on the development of drug candidates for leukemia and lymphoma. Abnormal epigenetic modification is recognized to play an important role in the pathogenesis of acute myeloid leukemia (AML), leading to silencing of genes involved in tumor suppression and cellular reproduction. Rasna’s focus on inhibition of lysine specific demethylase-1 (LSD1), an enzyme involved in epigenetic control, represents a promising and novel approach towards AML. Rasna has developed novel irreversible and reversible LSD1 regulators that have shown appropriate effects on the LSD1 gene in-vitro and in IND-enabling pre-clinical studies.

YEAR FOUNDED:

2013

LEADERSHIP:

Founders: Gabriele Cerrone, Roberto Pellicciari, and Brunangelo Falini

CEO: James Tripp



Key Statistics


Email: info@rasna.com
Ownership: Public

Web Site: Rasna Therapeutics
Employees:
Symbol: ATVM
 



Industry
Biotechnology






Company News
//-->